The maintenance of AMPK levels seems to be beneficial for the liver homeostasis, and the activation of AMPK may be of value for the prevention and treatment of metabolic disorders associated with obesity, such as type 2 diabetes mellitus and NAFLD13. Here, PRKAA2 is linked to obesity due to melanocortin 4 receptor deficiency.